neostigmine methylsulfate
Generic: neostigmine methylsulfate
Labeler: hikma pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
neostigmine methylsulfate
Generic Name
neostigmine methylsulfate
Labeler
hikma pharmaceuticals usa inc.
Dosage Form
INJECTION
Routes
Active Ingredients
neostigmine methylsulfate .5 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0641-6264
Product ID
0641-6264_2ddab018-16a5-455c-9f43-8e16533ae808
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207042
Listing Expiration
2026-12-31
Marketing Start
2015-12-28
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
06416264
Hyphenated Format
0641-6264
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
neostigmine methylsulfate (source: ndc)
Generic Name
neostigmine methylsulfate (source: ndc)
Application Number
ANDA207042 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/mL
Packaging
- 10 VIAL, MULTI-DOSE in 1 CARTON (0641-6264-10) / 10 mL in 1 VIAL, MULTI-DOSE (0641-6264-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2ddab018-16a5-455c-9f43-8e16533ae808", "openfda": {"unii": ["98IMH7M386"], "rxcui": ["311935", "311936"], "spl_set_id": ["28365ed5-8332-48ac-a93d-b165ac3c6eac"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (0641-6264-10) / 10 mL in 1 VIAL, MULTI-DOSE (0641-6264-01)", "package_ndc": "0641-6264-10", "marketing_start_date": "20151228"}], "brand_name": "Neostigmine Methylsulfate", "product_id": "0641-6264_2ddab018-16a5-455c-9f43-8e16533ae808", "dosage_form": "INJECTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0641-6264", "generic_name": "Neostigmine Methylsulfate", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine Methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": ".5 mg/mL"}], "application_number": "ANDA207042", "marketing_category": "ANDA", "marketing_start_date": "20151228", "listing_expiration_date": "20261231"}